[
  {
    "ts": "2025-12-30T12:59:00+00:00",
    "headline": "3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains",
    "summary": "Three dividend-paying pharma stocks stand out for steady 2026 gains as innovation, pricing deals and resilient drug demand support returns.",
    "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5a92206d-fd62-3bd8-a9b7-102f498ce9f9",
      "content": {
        "id": "5a92206d-fd62-3bd8-a9b7-102f498ce9f9",
        "contentType": "STORY",
        "title": "3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains",
        "description": "",
        "summary": "Three dividend-paying pharma stocks stand out for steady 2026 gains as innovation, pricing deals and resilient drug demand support returns.",
        "pubDate": "2025-12-30T12:59:00Z",
        "displayTime": "2025-12-30T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-dividend-paying-pharma-stocks-125900443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T18:31:52+00:00",
    "headline": "Investors should beware of AI's circular financing trap, look for alternatives like Broadcom",
    "summary": "Miramar Capital's Max Wasserman forecasts a \"broadening\" of the market in 2026.",
    "url": "https://finance.yahoo.com/news/investors-should-beware-of-ais-circular-financing-trap-look-for-alternatives-like-broadcom-183152653.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "9221c137-000c-4502-b138-25538a4aea14",
      "content": {
        "id": "9221c137-000c-4502-b138-25538a4aea14",
        "contentType": "STORY",
        "title": "Investors should beware of AI's circular financing trap, look for alternatives like Broadcom",
        "description": "",
        "summary": "Miramar Capital's Max Wasserman forecasts a \"broadening\" of the market in 2026.",
        "pubDate": "2025-12-30T18:31:52Z",
        "displayTime": "2025-12-30T18:31:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-12/fbdd1c80-e5a2-11f0-9dda-77a60fd91104",
          "originalWidth": 4745,
          "originalHeight": 3163,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zU0FsvoaC_2rzfUGq5o80A--~B/aD0zMTYzO3c9NDc0NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-12/fbdd1c80-e5a2-11f0-9dda-77a60fd91104.cf.webp",
              "width": 4745,
              "height": 3163,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/deA_zqPtfX9ov01T8hFeDw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-12/fbdd1c80-e5a2-11f0-9dda-77a60fd91104.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-should-beware-of-ais-circular-financing-trap-look-for-alternatives-like-broadcom-183152653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-should-beware-of-ais-circular-financing-trap-look-for-alternatives-like-broadcom-183152653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "HD"
            },
            {
              "symbol": "WM"
            },
            {
              "symbol": "MCD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T20:25:00+00:00",
    "headline": "3 No-Brainer Dividend Stocks to Buy Right Now",
    "summary": "You don't need to settle for an average dividend yield.",
    "url": "https://www.fool.com/investing/2025/12/30/3-no-brainer-dividend-stocks-to-buy-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f089ecfc-8f49-386a-a653-1db54a510f6b",
      "content": {
        "id": "f089ecfc-8f49-386a-a653-1db54a510f6b",
        "contentType": "STORY",
        "title": "3 No-Brainer Dividend Stocks to Buy Right Now",
        "description": "",
        "summary": "You don't need to settle for an average dividend yield.",
        "pubDate": "2025-12-30T20:25:00Z",
        "displayTime": "2025-12-30T20:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/7b635433d7bec1da7c87de2c24d543ed",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A happy person wearing a Santa hat and sitting at their computer in front of a Christmas tree.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VdtV4AlJhlOyZa4rv7lLtQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/7b635433d7bec1da7c87de2c24d543ed.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_OhjtnxTxabCeN.FZG.EgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/7b635433d7bec1da7c87de2c24d543ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/30/3-no-brainer-dividend-stocks-to-buy-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-no-brainer-dividend-stocks-202500676.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JEPQ"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "O"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T23:07:40+00:00",
    "headline": "BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, BofA lowered the firm’s price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating. The firm said it sees “a relatively clean setup” for growth near the top end of the […]",
    "url": "https://finance.yahoo.com/news/bofa-cuts-abbvie-abbv-target-230740908.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5ccd536f-b715-3fbf-a504-1a80f3df5405",
      "content": {
        "id": "5ccd536f-b715-3fbf-a504-1a80f3df5405",
        "contentType": "STORY",
        "title": "BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, BofA lowered the firm’s price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating. The firm said it sees “a relatively clean setup” for growth near the top end of the […]",
        "pubDate": "2025-12-30T23:07:40Z",
        "displayTime": "2025-12-30T23:07:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aXAa28AvezyRv056g_RUEg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lzVMSqWRbEKelBHS4c050A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bofa-cuts-abbvie-abbv-target-230740908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bofa-cuts-abbvie-abbv-target-230740908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BAC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]